Raven J. Reddy
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Cytokine Signaling Pathways and Interactions, Cell Image Analysis Techniques, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Early signaling dynamics of the epidermal growth factor receptor(2016)93 cited
- → Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma(2018)78 cited
- → Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance(2017)31 cited
- → Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer(2022)24 cited
- → Vascular Endothelial Growth Factor (VEGF) and Platelet (PF-4) Factor 4 Inputs Modulate Human Microvascular Endothelial Signaling in a Three-Dimensional Matrix Migration Context(2013)15 cited
- → Measurement of Phosphorylated Peptides with Absolute Quantification(2016)3 cited
- Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistance(2017)
- → Supplementary Table 3 from Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance(2023)
- → Supplementary Figures and Legends from Characterization of <i>In Vivo</i> Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance(2023)